Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature

by Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie Tcherny-Lessenot
Published 2020-12-01

Evaluating the “return on patient engagement initiatives” in medicines research and development: A literature review

by Lidewij Eva Vat, Teresa Finlay, Tjerk Jan Schuitmaker‐Warnaar, Nick Fahy, Paul Robinson, Mathieu Boudes, Ana Diaz, Elisa Ferrer, Virginie Hivert, Gabor Purman, Marie‐Laure Kürzinger, Robert A. Kroes, Claudia Hey, Jacqueline E.W. Broerse
Published 2020-02-01